相似文献
1
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy.
AAPS J. 2025 Mar 18;27(3):66. doi: 10.1208/s12248-025-01051-8.
2
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy.
Adv Immunol. 2025;166:37-75. doi: 10.1016/bs.ai.2025.02.001. Epub 2025 Mar 5.
3
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye.
J Control Release. 2025 Jul 12;385:114027. doi: 10.1016/j.jconrel.2025.114027.
4
The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery.
Eur J Pharm Sci. 2025 Jun 24:107182. doi: 10.1016/j.ejps.2025.107182.
5
Biodegradable polymers with tertiary amines enhance mRNA delivery of lipid nanoparticles via improved endosomal escape.
Biomaterials. 2026 Jan;324:123541. doi: 10.1016/j.biomaterials.2025.123541. Epub 2025 Jul 8.
6
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.
Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9.
7
Engineering Lipid Nanoparticles for mRNA Immunotherapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Mar-Apr;17(2):e70007. doi: 10.1002/wnan.70007.
8
Lipid Nanoparticles Consisting of Sterol-Conjugated Ionizable Lipids Enable Prolonged and Safe mRNA Delivery.
ACS Appl Mater Interfaces. 2025 Jun 18. doi: 10.1021/acsami.5c08444.
9
A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs.
J Control Release. 2025 Aug 10;384:113879. doi: 10.1016/j.jconrel.2025.113879. Epub 2025 May 21.
10
The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting.
J Control Release. 2024 Jun;370:516-527. doi: 10.1016/j.jconrel.2024.05.006. Epub 2024 May 9.
引用本文的文献
1
Pia Mater-Penetrable Lipopolymer Nanoparticles for Gliocyte-Targeted IL-10 mRNA Therapy Alleviate Paclitaxel-Induced Peripheral Neuropathy.
Adv Sci (Weinh). 2025 Jun;12(23):e2500362. doi: 10.1002/advs.202500362. Epub 2025 May 13.
本文引用的文献
1
Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions.
J Pers Med. 2024 Nov 4;14(11):1092. doi: 10.3390/jpm14111092.
2
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity.
Sci Adv. 2024 Oct 11;10(41):eadn9961. doi: 10.1126/sciadv.adn9961.
3
Effectiveness and Safety of mRNA Vaccines in the Therapy of Glioblastoma.
J Pers Med. 2024 Sep 19;14(9):993. doi: 10.3390/jpm14090993.
4
Tailoring lipid nanoparticle dimensions through manufacturing processes.
RSC Pharm. 2024 Sep 23;1(4):841-853. doi: 10.1039/d4pm00128a. eCollection 2024 Oct 15.
5
mRNA vaccines: a new era in vaccine development.
Oncol Res. 2024 Sep 18;32(10):1543-1564. doi: 10.32604/or.2024.043987. eCollection 2024.
6
Lipid nanoparticle-mediated RNA delivery for immune cell modulation.
Eur J Immunol. 2024 Dec;54(12):e2451008. doi: 10.1002/eji.202451008. Epub 2024 Sep 16.
7
Acid-degradable lipid nanoparticles enhance the delivery of mRNA.
Nat Nanotechnol. 2024 Nov;19(11):1702-1711. doi: 10.1038/s41565-024-01765-4. Epub 2024 Aug 23.
8
Enhancing spleen-targeted mRNA delivery with branched biodegradable tails in lipid nanoparticles.
J Mater Chem B. 2024 Aug 22;12(33):8062-8066. doi: 10.1039/d4tb00960f.
9
Lipid Nanoparticle-mRNA Engineered Dendritic Cell Based Adoptive Cell Therapy Enhances Cancer Immune Response.
Small Methods. 2025 Jan;9(1):e2400633. doi: 10.1002/smtd.202400633. Epub 2024 Jul 23.
10
Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation.
Nat Commun. 2024 Jul 5;15(1):5659. doi: 10.1038/s41467-024-50093-7.
Zotero 插件